Navigation Links
Brain & Behavior Research Foundation awards nearly $4 million in new NARSAD grants
Date:3/21/2013

decreases in both glutamate and dysbindin, and decreases in glutamate release also appear in dysbindin-deficient mice that the Lavin lab will use as experimental models.

Todd Lencz, Ph.D., of The Feinstein Institute for Medical Research, aims to identify rare genetic variants associated with schizophrenia by utilizing DNA from an Ashkenazi Jewish population, in which there is much less genetic variation than in the general public. Preliminary testing of a small number of Ashkenazi subjects with schizophrenia identified a set of possible candidate genes that Dr. Lencz now intends to pursue in a larger number of participants.

Daniel J. Mueller, M.D., Ph.D., of the Centre for Addiction and Mental Health, is exploring the genetics of the weight gain caused by antipsychotic medications. Commonly prescribed drugs for schizophrenia like clozapine and reserpine induce substantial weight gain in up to half of patients, posing risks for serious illness and for treatment noncompliance. Dr. Mueller and colleagues are working to identify the responsible gene variants and their role in antipsychotic-induced weight gain and possibly in obesity generally.

Brien P. Riley, Ph.D., of Virginia Commonwealth University, proposes to sequence all protein-coding DNA in the genomes of a group of Irish patients with schizophrenia in multiple affected families in order to identify rare, damaging genetic variations. Such families have a substantially higher risk of illness than the general population, and likely harbor gene variations with greater impact in the causation of a disease in which hundreds of variants have been implicated.

Multiple Disorders

Alon Chen, Ph.D., of the Weizmann Institute of Science, is studying the role of microRNAs, molecules that repress gene expression, in regulating the brain chemical serotonin in depression and anxiety. Levels of brain microRNAs are affected by behavioral and pharma
'/>"/>

Contact: Sally Corbett
scorbett@bbrfoundation.org
516-829-0091 x242
Brain & Behavior Research Foundation
Source:Eurekalert

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology news :

1. Obama calls Ben-Gurion U. brain research a great idea
2. Reward linked to image is enough to activate brains visual cortex
3. Atypical brain circuits may cause slower gaze shifting in infants who later develop autism
4. Wireless, implanted sensor broadens range of brain research
5. University of Maryland School of Medicine finds depression stems from miscommunication between brain cells
6. Pig brain models provide insights into human cognitive development
7. Computer model may help athletes and soldiers avoid brain damage and concussions
8. Tickling the brain with magnetic stimulation improves memory in schizophrenia
9. Oxfords Gero Miesenböck is awarded The Brain Prize 2013 for his pioneering work on optogenetics
10. Even mild traumatic brain injuries can kill brain tissue
11. Researchers discover workings of brains GPS system
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2014)... 2014  Wake Forest Baptist Medical Center today announced plans ... of Medicine. Funding for this $50 million capital project ... be publicly launched next summer. The ... 60 series R.J. Reynolds Tobacco Company complex, adjacent to ... immediately with plans to be ready to welcome medical ...
(Date:12/10/2014)... Research and Markets ( http://www.researchandmarkets.com/research/xclcvw/biometrics_market ... "Biometrics Market in Japan 2014-2018" report to ... The integration of biometrics and ... and upgradation of the driver,s license is one ... Besides the aforementioned projects, biometrics is being used ...
(Date:12/5/2014)... Calif. , Dec. 4, 2014 ... has boosted investments in new testing and inspection ... also given rise to a range of innovative ... the requirements of Generation Y, which is generally ... As a result, product development strategies of test ...
Breaking Biology News(10 mins):Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4
... biologists at the University of Pennsylvania say that species ... rate than in the past. In the study, ... researchers developed a novel computational approach to infer the ... present-day species. Using nine patterns of diversification as ...
... State University researchers have received a $1.5 million ... better account of their ecological footprint., Seven researchers ... Natural Resources, Biosystems Engineering, and USDA Agricultural Research ... nitrogentwo elements central to farming and out of ...
... more than $4.5 million, from agencies of the National ... treatment strategies for muscular dystrophy. The grants were ... and Skin Diseases (NIAMS), National Institute of Neurological Disorders ... of Child Health and Human Development (NICHD) for year ...
Cached Biology News:Penn biologists say species accumulate on Earth at slower rates than in the past 2WSU researchers taking sustainability of organic farming to new level 2NIH awards Muscular Dystrophy Cooperative Research Center grants 2
(Date:12/24/2014)... PharmaBoardroom,s new report, , ... available for free download , digs deep into this ... in the sector today. One area where ... in developing a homegrown pharmaceutical manufacturing base, even if the ... some way off. A cursory comparison with neighboring ...
(Date:12/22/2014)... , Dec. 22, 2014   ... a developer of pathogen-specific therapies for serious ... protecting the microbiome, today announced positive topline ... 1a clinical trial of SYN-004, the Company,s ... of Clostridium difficile (C. difficile) ...
(Date:12/22/2014)... 2014 The American Journal ... original research, reviews and editorials addressing developments and ... today published a provocative article exploring the role ... and potential treatment of prostate cancer. , ... proposes the possibility that there could be a ...
(Date:12/19/2014)... December 19, 2014 BioPlus Specialty ... pharmacies, announces the promotion of Nick Maroulis, Pharm.D. to ... Pharmacy Services. , In this position, Dr. Maroulis ... also managing the directors of our multi-site pharmacies as ... since 1997 and during that time he has served ...
Breaking Biology Technology:PharmaBoardroom Releases New Algeria Pharmaceuticals Report 2PharmaBoardroom Releases New Algeria Pharmaceuticals Report 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 2Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 4Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 5Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 3Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 4BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2
... , , , The proven activated dendrimer for transfection , ... Features and benefits , , ... Suitable for a broad range of cell lines , Transfection in ... Quantity vs. Transfection Efficiency ") , High transient and stable transfection ...
... , , , For transfection of a wide variety of cells, , ... Features and benefits , , ... transfection-complex removal needed for most cell lines , Transfection in the ... lines , High transfection efficiencies and minimal cytotoxicity, ...
... , , , , ... and Rosemarie Grantyn , Developmental Physiology, Johannes Mller ... , , Efficient ... importance for extending our knowledge of the molecular basis of neuronal ...
Cached Biology Technology:SuperFect Transfection Reagent 2SuperFect Transfection Reagent 3Effectene Transfection Reagent 2Effectene Transfection Reagent 3Effectene Transfection Reagent 4Effectene Transfection Reagent provides efficient gene delivery , to primary neuronal cell cultures 2Effectene Transfection Reagent provides efficient gene delivery , to primary neuronal cell cultures 3Effectene Transfection Reagent provides efficient gene delivery , to primary neuronal cell cultures 4
... shortages in your laboratory or fellow researchers want ... problems and delays. • ... Bring us your idea and let us build ... under ISO 9001 quality assurance in design, development, ...
...
... virus is a type I eukaryotic topoisomerase ... turns (also called right- and left-handed supercoils) ... the reaction is a covalently closed, circular ... turns. DNA Topoisomerase I does not absolutely ...
Applications include ELISA, immunochemistry, and Western blotting. Working Concentrations: ELISA: 0.005-0.05 U/ml, immunohisto/cytochemistry: 0.25-0.5 U/ml, Western blot: 0.1-0.25 U/ml....
Biology Products: